How half the batches achieved twice the results
Sometimes, the future of a client's entire company is riding on the success of one trial. That was the case when a small client came to Tony looking for a formulation solution for a revolutionary treatment. The problem was, their clinical trial protocol, as originally written, required six blinded doses. But the client could only afford to produce three batches, not six. If they couldn't complete this trial milestone, the company was at risk of going out of business. When the client presented Tony with the issue, he recommended an adjustment to the trial protocol that would ensure they could gather the clinical data they needed with just three batches. By changing the clinical protocol, the trial the client thought was beyond their reach, suddenly became possible. And now this small company could move forward to make a big impact.
Hear directly from Tony Pidgeon, Process Technology Director, Pharma Services, at Patheon, to understand how this was achieved: